Key statistics
As of last trade, AN2 Therapeutics Inc (ANTX:NSQ) traded at 1.35, 55.14% above the 52 week low of 0.87 set on Aug 09, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.26 |
---|---|
High | 1.42 |
Low | 1.26 |
Bid | 1.34 |
Offer | 1.35 |
Previous close | 1.23 |
Average volume | 1.89m |
---|---|
Shares outstanding | 29.88m |
Free float | 23.41m |
P/E (TTM) | -- |
Market cap | 36.75m USD |
EPS (TTM) | -2.04 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 17:00 GMT.
More ▼
- AN2 Therapeutics to Participate at Upcoming Investor Conferences
- AN2 Therapeutics Reports Third Quarter 2024 Financial Results, Provides Important EBO-301 Update and Highlights Progress Across Boron Chemistry Pipeline
- AN2 Therapeutics Receives Continuation Grant to Discover Novel Boron Based Therapies for Tuberculosis (caused by Mycobacterium tuberculosis) and Malaria
- AN2 Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference